Cannabis-related healthcare encounters among U.S. commercially insured adults
1US Food and Drug Administration, Silver Spring, MD, USA.
Related Experiment Videos
View abstract on PubMed
Summary
Cannabis-related healthcare encounters increased significantly among insured adults aged 18-64 from 2017 to 2022. This trend occurred across all age groups and care settings, regardless of state cannabis laws.
Area of Science:
- Public Health
- Healthcare Analytics
- Cannabis Research
Background:
- Recent studies indicate rising cannabis-related healthcare encounters among older adults, particularly in states with legalized cannabis.
- Understanding these trends in younger adult populations is crucial given increased cannabis access.
Purpose of the Study:
- To assess temporal trends in cannabis-related healthcare encounters among commercially insured adults aged 18-64 years in the United States.
- To examine these trends in relation to care setting, age group, and state cannabis legal status.
Main Methods:
- A descriptive study utilized administrative claims data from four national health insurers (2017-2022).
- Cannabis-related healthcare encounters were identified using ICD-10-CM diagnosis codes.
- Analyses included annual encounter rates, stratified by care setting, age, and state cannabis legal status.
Main Results:
- Over 5.6 million cannabis-related encounters were identified among nearly 115 million eligible individuals.
- Annual encounter rates increased from 44.0 to 75.1 per 10,000 person-years between 2017 and 2022.
- Increasing trends were observed across all age groups and care settings, with no significant differences noted based on state cannabis legal status.
Conclusions:
- Findings suggest an evolving cannabis landscape characterized by increased use, legalization, product potency, and decreased risk perception.
- The rise in healthcare encounters highlights the need for further research into factors like race, socioeconomic status, and clinical characteristics.
- These trends underscore the importance of monitoring public health impacts associated with changing cannabis policies and use patterns.